Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Moderna Inc (MRNA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Moderna's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
105.11 +1.25    +1.21%
17:16:55 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 1,140,411
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 101.30 - 106.42
Type:  Equity
Market:  United States
Moderna 105.11 +1.25 +1.21%

NASDAQ:MRNA Financials

 
This summary provides an overview of the most significant critical numbers from each of the Moderna Inc financial reports, including theModerna Inc income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NASDAQ:MRNA financials over time via breakdowns of their annual reports.

Moderna, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 2,811 million compared to USD 5,084 million a year ago. Net income was USD 217 million compared to USD 1,465 million a year ago. Basic earnings per share from continuing operations was USD 0.57 compared to USD 3.81 a year ago. Diluted earnings per share from continuing operations was USD 0.55 compared to USD 3.61 a year ago.For the full year, revenue was USD 6,848 million compared to USD 19,263 million a year ago. Net loss was USD 4,714 million compared to net income of USD 8,362 million a year ago. Basic loss per share from continuing operations was USD 12.33 compared to basic earnings per share from continuing operations of USD 21.26 a year ago. Diluted loss per share from continuing operations was USD 12.33 compared to diluted earnings per share from continuing operations of USD 20.12 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

MRNA Income Statement & Profits

Gross margin TTM -39.28%
Operating margin TTM -61.9%
Net Profit margin TTM -68.84%
Return on Investment TTM -20.58%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 2811 1831 344 1862
Gross Profit 476 -1570 -1535 -61
Operating Income 6 -2012 -1867 -366
Net Income 217 -3630 -1380 79

MRNA Balance Sheet

Quick Ratio MRQ 3.15
Current Ratio MRQ 3.42
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 8.97%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 18426 19450 21884 24125
Total Liabilities 4572 5995 4935 5262
Total Equity 13854 13455 16949 18863

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM -8.18
Revenue/Share TTM 17.96
Operating Cash Flow  20.63%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 622 -1600 -915 -1225
Cash From Investing Activities -538 789 1944 2011
Cash From Financing Activities -109 -58 -668 -542
Net Change in Cash -25 -869 361 244
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRNA Price Commentary

Write your thoughts about Moderna Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
John Williams
John Williams Nov 02, 2023 11:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$69.50…
Ken Laing
Ken Laing Oct 26, 2023 5:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
At some point this will be a buy
John Williams
John Williams Oct 17, 2023 17:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hype stock. Trading pharma stocks is tedious at best, in this case, unrewarding too. I wouldn’t bother unless I heard news of a serious covid strain - the kind that sends crude oil down at least 10-15%.
Ferdinand Peelen
Ferdinand Peelen Aug 17, 2023 15:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What's up with Moderna today?
John Williams
John Williams Aug 07, 2023 16:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Told ya.
John Williams
John Williams Mar 30, 2023 21:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sc mortgage should dump this
Al Al
Al Al Mar 30, 2023 21:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They have high conviction in this, they believe it offers the best growth story and new drugs in the works.
Puk Pups
Puk Pups Feb 24, 2023 10:28
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone interested buy for $100 in 2023 ?
JASWANT SINGH
JASWANT SINGH Dec 13, 2022 16:13
Saved. See Saved Items.
This comment has already been saved in your Saved Items
come back 150 below
Randy Mayaba
Randy Mayaba Sep 29, 2022 13:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
notify me when it's at 110
Ken Laing
Ken Laing May 06, 2022 23:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Getting close to my buying target
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email